No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
BSEM BIOSTEM TECHNOLOGIES INC
- 12.650
- -0.175-1.36%
15min DelayClose Dec 27 16:00 ET
206.45MMarket Cap-17.33P/E (TTM)
13.100High12.500Low24.77KVolume12.500Open12.825Pre Close314.43KTurnover0.15%Turnover RatioLossP/E (Static)16.32MShares28.25752wk High-58.56P/B206.45MFloat Cap6.77052wk Low--Dividend TTM16.32MShs Float28.257Historical High--Div YieldTTM4.68%Amplitude6.770Historical Low12.695Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Press Release: BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies From ProgenaCare Global
Express News | Biostem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies From Progenacare Global
Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q3 Revenue $82.6M
Earnings Preview: BSEM to Report Financial Results Post-market on November 12
$BIOSTEM TECHNOLOGIES INC(BSEM.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $BIOSTEM TECHNOLOGIES INC(BSEM.US)$ to post revenue
BioStem Gains on Medicare National Pricing for Wound Care Product
Express News | Biostem Technologies Inc - Trial Expected to Complete by End of 2025
Heat List
US
Overall
Symbol
Price
% Chg
No Data